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Abstract
Background: In the Dutch colorectal cancer (CRC) screening programme, individuals receive a
faecal immunochemical test (FIT) to do at home. After a positive FIT result, a follow-up colonoscopy
is recommended to identify CRC or advanced adenomas (AA). GPs may influence their patients’
decisions on adherence to follow-up by colonoscopy.
Aim: To explore GPs’ perspectives on the CRC screening programme and their potential influence
on FIT-positive patients to follow up with the recommended colonoscopy.
Design & setting: Semi-structured interviews among GPs in Amsterdam, the Netherlands.
Method: GPs were approached using purposive sampling. Analysis was performed on 11
interviews using open coding and constant comparison.
Results: All interviewed GPs would recommend FIT-positive patients without obvious
contraindications to adhere to a follow-up colonoscopy. If patients were likely to be distressed by a
positive FIT result, most GPs described using reassurance strategies emphasising a low cancer
probability. Most GPs stressed the probability of false-positive FIT results. Some described taking a
positive screening result in CRC screening less seriously than one in breast cancer screening. Most
GPs underestimated CRC and AA probabilities after a positive FIT result. When told the actual
probabilities, some stated that this knowledge might change the way they would inform patients.
Conclusion: These results imply that some of the interviewed GPs have too low a perception of the
risk associated with a positive FIT result, which might influence their patients’ decision-making.
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Simply informing GPs about the actual rates of CRC and AA found in the screening programme
might improve this risk perception.
How this fits in
Previous research has suggested that GPs can guide their patients’ decisions on participating in CRC
screening and having a follow-up colonoscopy after a positive screening result. This qualitative study
describes how this process may be influenced by factors such as GPs’ experience, attitudes, and
knowledge with respect to screening. The authors suggest how GPs may be supported to give well-
informed advice to their patients.
Introduction
In 2014, a nationwide screening programme for CRC was implemented in the Netherlands.1 After
breast cancer and cervical cancer screening programmess, this is the third nationwide cancer screen-
ing programme in the Netherlands, and the first one in which males are included.2,3 In the CRC
screening programme, all males and females aged 55–75 years receive an FIT biennially, with the
aim of detecting faecal blood. In case of a positive result (detection of blood), a colonoscopy is rec-
ommended to identify relevant abnormalities: CRC or AA. In 2016, 73.0% of the invited population
participated in the Dutch programme, which is the highest participation rate in an organised screen-
ing setting worldwide.4,5 At the end of 2017, close to 2 million Dutch individuals had received an
invitation for the screening programme.6
GP involvement in the Dutch CRC screening programme
The Dutch screening programme is coordinated by the National Institute of Public Health and Envi-
ronment (RIVM). GPs do not have a formal role in the screening logistics. This is similar to the CRC
screening programs in Australia7 and the UK,8 but different from other countries. In France, for
example, which also has a population-based FIT screening programme, individuals who receive an
invitation to screen need to request the FIT from their GP.9 In countries with opportunistic screening
programs (like the US,10 Italy,11and Turkey),12 the initiative to screen may lie entirely in the hands of
the GP or the individual.
Until December 2017, Dutch GPs were informed about their patient’s positive FIT results 2 days
before the patient received the result by post. This gave them the opportunity to contact their
patient if desired. FIT-positive individuals were notified of a scheduled appointment for an intake
visit in a colonoscopy centre nearby and were encouraged to seek contact with their GP.4,13 They
were requested to bring a copy of their medical history and current medication to the intake visit,
preferably obtained from their GP.14
GPs no longer informed about positive FIT results
As of December 2017, Dutch GPs no longer receive standard notifications of their patients’ positive
FIT results from RIVM, unless the patient has contacted RIVM directly with the request to do
so.15 For two reasons, however, some GP involvement is still to be expected. Firstly, the information
brochure that invitees to the screening receive mentions that individuals who have questions with
regards to participation in the screening are advised to visit their GP.16 Secondly, the information
brochure that individuals with a positive FIT receive still states that this group should collect their
patient history at their GPs’ practice and discuss this history with their GP before the intake
appointment.17
ARCUS study
This study is part of a set of studies performed under the umbrella ARCUS (Amsterdam Research on
Colonoscopy Uptake after Screening). The aim of this study is to understand why some FIT-positive
screenees do not undergo a colonoscopy (17.3% in 2016).4 Figures from RIVM’s 2016 annual
report4 showed that 30.2% of FIT-positive screenees who cancelled their appointment for a colonos-
copy intake reported having done so based on the advice of their GP. This was the impetus for this
study. Interviews have also been carried out with FIT-positive participants about their reasons to
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decline or go through with the colonoscopy. The results of these interviews will be published at a
later stage.
GP influence on screening behaviour
It is internationally well-documented that physicians’ attitudes, recommendations, and behaviour
may influence their patients’ decisions to participate in CRC screening and having follow-up after a
positive FIT result.7,9,12,18–22 For instance, it has been reported that GPs can increase screening par-
ticipation among their patients: providing GPs with a list of non-adhering patients contributes to
slightly higher rates of uptake of FIT,20 GP involvement instead of hospital involvement can increase
CRC screening participation,11 and a GP-endorsed reminder letter is more effective than a standard
reminder letter in increasing uptake in CRC screening.23,24
Contrarily, some research suggests that GPs can also reduce screening participation in their
patients. GPs can legitimately filter out patients that are unsuitable for CRC screening,25 as has been
the case in previous studies which showed that GPs tend not to offer CRC screening when patients
are receiving end-of-life care, are already under colonoscopy surveillance, do not have a colon, or
have recently received a diagnosis of CRC.10,26 However, it has also been suggested that physicians
can reduce screening participation for less justifiable reasons; previous research indicates that GPs
can have difficulties in dealing with scientific arguments related to CRC screening, and with separat-
ing personal experience from public health data.9 Furthermore, discussions about screening options
between GP and the patient may lack quality22,27 and GPs may be insufficiently aware of current
CRC screening guidelines. They may, as a result, give inappropriate recommendations with regard
to a follow-up colonoscopy after a positive FIT result.9,10,28 An Italian study found that 32% of GPs
recommended inappropriate follow-up tests for patients with a positive FIT result.28 Underlying GP-
related factors that are associated with the above circumstances are a heavy workload, insufficient
training with regard to screening, and a lack of trust in the relevance of screening.9,11 Overall,
screening participation of patients tends to be very variable among different GPs,20 which may
account for the diversity in findings among the studies mentioned.
As the above evidence demonstrates, GP influence on screening behaviour might be an interna-
tional phenomenon. For that reason, this study might provide relevant information that extends
beyond Dutch borders.
Method
This study was performed in Amsterdam from May–August 2017. A purposive sampling strategy was
used to ensure an equal distribution of GPs throughout the city.27,29 GPs were selected from eight
different districts in Amsterdam, using Google Maps. The Dutch search term ‘huisarts’ (translation of
’GP’) was entered in each of the eight districts on Google Maps and the practices that showed up
were put on a list. In each district, two to five GPs were approached by telephone. If they declined,
the next GPs two to five on the list were approached.
A semi-structured interview guide was used (further information availabe from the authors on
request). The interviews were conducted by one member of the research team (a final year medical
student) under the supervision of another (a medical anthropologist and sociologist, and PhD candi-
date) and lasted between 20–50 minutes. A consent form was signed by both interviewee and inter-
viewer, in which the latter agreed to ensure the anonymity of the former. The interviews were
conducted at either the GP practice or the department of general practice of the University of
Amsterdam, and were audiorecorded and transcribed verbatim by the interviewer. The quotes in
this report were translated from Dutch to English by three members of the research team (the inter-
viewer, the supervisor, and a PhD-holding GP).
Coding, using MAXQDA (version 12), involved three stages: open coding, axial coding, and selec-
tive coding.30,31 Data collection and data analysis ran alongside each other to make constant com-
parison possible. This also enabled the determination of data saturation. Data saturation was
defined as the point at which any new data were unlikely to alter the results.30,31 Results were
defined as both the main themes and the sub-themes. All interviews were coded by the interviewer
and supervisor independently, after which they and the PhD-holding GP discussed the results until
agreement was reached.




Of the 89 eligible GPs that were approached, 11 agreed to participate in an interview (31 non-res-
ponders, 47 active decliners). Reasons for non-participation were lack of time (n = 29), lack of inter-
est (n = 9), and having a young patient population (n = 4). Data saturation was reached after nine
interviews. The GP characteristics are shown in Table 1. One of the eight districts from which GPs
were selected was not represented (district South), as none of the 16 GPs who were approached
participated. In each of the seven other districts, one or two GPs participated. A complete list of the
themes and sub-themes found is available from the authors on request.
Experience with the national CRC screening programme
Three GPs mentioned having experienced CRC detection through the screening programme, either
via patients or personally. The interviewed GPs described receiving few questions about the screen-
ing. None of the GPs actively kept track of the number of positive FIT results in their practice.
Patients’ questions
When patients did visit their GP with questions about the screening programme, these involved four
different themes: participation in FIT screening, instructions about the FIT or explanations of the
screening procedure, logistical issues (rescheduling a colonoscopy appointment or asking when the
results were expected), and colonoscopy issues (whether or not to participate and what to expect).
Questions about instructions came especially from individuals with limited literacy or a migrant back-
ground. The interviewed GPs saw difficulties with understanding the information provided by the
screening organisation in these groups in particular:
‘One of my patients sent in a tube filled with just pure blood. He showed me what he did. He
had forcibly put the test-tube entirely into his rectum, thinking "That’s where the stool is, so
that’s where I have to gather it".’ (GP2)
A few GPs described adjusting the information they wanted to convey to their patient, especially
if they encountered communication problems. They did so by choosing different words than they
otherwise would, or by simplifying information:
Table 1. Characteristics of participating GPs (n = 11)
Characteristic n (%)























Population described as ’multicultural’ by GPb 6 (55)







aOne starting and one retiring from practice. bTerms used were ’multicultural’, ’migrant’, and ’foreigners’.
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‘You try to adjust your information to someone’s level of understanding.’ (GP8)
Follow-up after a positive FIT result
Seeking contact
Four of the interviewed GPs described taking the opportunity to contact their patients before they
received the news about a positive FIT result from the screening organisation.
Advising follow-up investigation
The GPs described recommending a colonoscopy to all FIT-positive patients, except in the following
situations: having had a recent colonoscopy, regularly visiting a specialist for colon-related condi-
tions, severe comorbidity, or having previously discussed not wanting treatment for serious condi-
tions. However, there was a large variability in the strength of this recommendation. Two GPs would
try to persuade a patient who was not inclined to go for a colonoscopy:
‘Yes, I strongly advise them to indeed do it. “Yeah but, I don’t want to, I don’t have time.” Well,
come here then, I will explain it to you again.’ (GP9)
One GP was at the other end of the spectrum in telling their patient not to expect anything:
‘There are people who ask, "Shall I go?" I tell them not to expect anything, but go ahead. There
is never really actually anything there. A polyp they take out.’ (GP3).
Most GPs, however, emphasised the importance of taking the patient’s viewpoint into account.
They mentioned their own freedom to advise as well as their patient’s right to make their own deci-
sions, which could include trying to learn more about the patient’s attitude before advising on what
to do:
‘I wouldn’t say per se "You have to do it". If someone has a good reason not to, than that’s fine
of course.’ (GP8)
The potentially distressed patient
A disadvantage of the screening programme, as the interviewed GPs experience it, is the potential
anxiety that patients might endure in case of a positive FIT result:
‘I think the biggest disadvantage is the uncertainty that sometimes goes with it [. . .] that,
regardless of the result, even waiting for that result can be stressful.’ (GP6).
Six GPs described strategies of dealing with a potentially distressed patient in an effort to pre-
vent or alleviate extreme worry. One of these strategies entailed disclosing all information over the
phone. Another strategy was the use of stronger reassurance in patients who they believed would
easily panic. Most of these GPs described telling their potentially distressed patients that the blood
found in the stool does not have a direct link with cancer. They talked about how it could also be
caused by a more benign condition such as haemorrhoids, polyps, or diverticulitis:
‘I know there are people who are just a bit panicky in nature. I try to tell them that, really . . . We
really don’t know what’s going on yet, so you shouldn’t worry yet.’ (GP1)
Attitude towards the CRC screening programme
Attitude towards screening in general
Of all interviewed GPs, two were very positive and nine were moderately positive about screening in
general, under the condition that the benefits outweigh the drawbacks. GPs mentioned that screen-
ing should be meaningful, implying that it should lead to early treatment and subsequently pro-
longed life. They stated the probability of a relevant finding should be substantial and the burden
and potential harm should be minimal.
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Attitudes towards the CRC screening programme
Two other GPs than the ones that were very positive about screening in general, were very positive
about the CRC screening programme specifically. Three GPs stated that they considered FIT with
subsequent colonoscopy the gold standard in screening for CRC. Two GPs had no opinion and said
they were awaiting proof of the efficacy of the programme. The remaining GPs described a moder-
ately positive attitude. Advantages of the screening programme mentioned were the timely diagno-
sis and the low burden of the FIT. Disadvantages mentioned were the invasiveness of the follow-up
colonoscopy, a high rate of false-positive FIT results, anxiousness in patients, and the risk of compli-
cations during colonoscopy.
Comparison with other screening programmes
Three GPs indicated taking a positive screening result less seriously in CRC screening than in breast
cancer screening. These GPs mentioned they were more likely to contact their patients with a posi-
tive mammography result than patients with a positive FIT result. A reason mentioned was that a
positive mammography result is highly indicative for cancer, whereas a positive FIT result is not nec-
essarily indicative for cancer:
‘It’s just a low risk thing. A positive result doesn’t have to be anything of course, while with the
breast cancer screening, if they find something then it’s usually cancer. But this, it could just be a
haemorrhoid or a polyp or whatever.’ (GP10).
Interpretation of a positive FIT result
Seven GPs discussed the probability of false-positive FIT results. They mentioned that blood in the
stool does not necessarily indicate a presence of CRC. Furthermore, they mentioned the low a priori
chance of anything meaningful being detected by screening and the high probability of haemor-
rhoids being the cause the positive result:
‘... you know you get a lot of false-positives because people have some blood in their bowels
that doesn’t have to mean anything.’ (GP4)
By contrast, three GPs mentioned being aware of the chances of a false-negative FIT result and
consequent risk of false reassurance. Four GPs discussed what to do with people having complaints
that could fit a diagnosis of CRC, suggesting that these patients should undergo colonoscopy as FIT
is not sufficient as a diagnostic tool in these cases.
Knowledge of the CRC screening programme
Finding information
The interviewed GPs described finding information on the screening programme in several ways.
Sources for information mentioned were an information session organised by the screening organisa-
tion in the early stages of the screening, an online information course for GPs, websites, and special-
ist GP magazines. However, the majority of GPs said they had never done an extensive search on
information about CRC screening, mainly because the screening programme is only a small part of
their daily practice. This is reflected by remarks made by several GPs about not being aware of cer-
tain aspects of the screening. These include knowledge of an online invitation agenda that shows
when certain birth cohorts are due for a screening invitation; the protocol for positive patients to ask
their GP for their medical history and medication overview for a colonoscopy intake; and the fact
that patients with a negative FIT result who have colon-related complaints may still have CRC.
Estimations of screening outcomes
The GPs were asked to estimate the percentage of positive FIT results as well as the combined prob-
ability of CRC and AA after a positive FIT result in the national screening programme in 2015, which
were the most recent data available at the time of the interviews. The estimations are presented
in Table 2.
For the FIT positive outcomes, seven GPs estimated a higher rate than the actual percentage of
6.4%.32 Three GPs estimations were too low, ranging between 2% and 3%, and one mentioned a
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correct estimation range of 4–12%. For the estimation of the combined probability of CRC and AA
at colonoscopy after a positive FIT result, seven GPs estimated a lot lower than the actual percen-
tages. Four GPs estimated percentages closer to the actual percentage, ranging between 40% and
50%. When the interviewer mentioned the actual percentages found, five GPs responded with
surprise:
‘Wow! That’s an eye opener because then I could maybe go into that conversation in a different
way.’ (GP4)
As the quotes above demonstrate, some of the interviewed GPs found this information useful
and mentioned that it might change the way they discuss the result with their FIT-positive patient or
how strongly they would advise a follow-up investigation.
GPs were informed of the risks associated with a positive FIT. The GPs who were not aware of




GPs described that the few patients who have questions with regards to CRC screening are looking
for advice on four main themes: participation in FIT screening, explanation of the screening proce-
dure, logistics, and follow-up after a positive FIT result. For potentially distressed patients with a
positive FIT result, most of the GPs described using strategies to prevent too much worry. All GPs
would recommend patients to undergo colonoscopy after a positive FIT result if there are no obvi-
ous contraindications. However, the strength of this recommendation varies substantially among
GPs. In that context, most GPs emphasise the right of patients to make their own decisions.
The interviewed GPs reported a positive attitude towards screening in general and a moderately
positive attitude towards the CRC screening programme. Advantages mentioned are the increased
chance of timely diagnosis and the low burden of FIT. Disadvantages mentioned are the invasiveness
of follow-up colonoscopy, a high rate of false-positive results, anxiousness in patients with a positive
FIT result, and the risk of complications during colonoscopy. However, the GPs believe that the ben-
efits outweigh the drawbacks. Some GPs tended to take a positive screening result for CRC less seri-
ously than for breast cancer. In that context, most GPs emphasise the high probability of a positive
FIT result turning out to be false-positive. On the other hand, some GPs highlight the dangers of
unjustified reassurance in cases of a false-negative FIT result.
The interviewed GPs find information about the screening programme mainly online or in medical
scientific journals. Most GPs had never done an extensive search for information, because the
screening is only a small part of their daily practice. Several GPs seem to lack awareness about cer-
tain aspects of the screening. When asked to estimate the probability of a positive FIT result and the
combined probability of CRC and AA being found during follow-up colonoscopy, most GPs estima-
tions were not correct (the latter often being too low). When told the actual percentages, almost
half of the interviewed GPs reacted with surprise and some stated that this might change the way
they inform their FIT-positive patients.
Table 2. GPs’ estimations: percentage of positive FIT results and combined probability of CRC and AA
Interview 1 2 3 4 5 6 7 8 9 10 11 Provided by RIVM32
Positive FIT, % 10 10–15 60 4–12 10 10 3 2 3 15 15–30 6.4
CRC or AA, % 10 40–45 20 12–16 10 40 30–35 20 40 2–5 40–50 Total 57.2
CRC 8.7
AA 48.5
AA = advanced adenomas. CRC = colorectal cancer. FIT = faecal immunochemical test. RIVM = National Institute of Public Health and Environment
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Strengths and limitations
This study presents new information concerning the experiences, attitudes, and knowledge in rela-
tion to the Dutch based CRC screening programme of GPs based in Amsterdam. A relatively small
number of GPs were interviewed due to a high rate of non-response and non-participation, which
may be explained by the fact that the interviews were done during the summer holidays.
Furthermore, all interviewed GPs turned out to have a positive attitude towards screening.
Although this might be seen as a limitation, it makes these results valid for a very specific and rele-
vant group of GPs, namely those who are most likely to be involved in optimisation of the screening
programme. As the authors suspect that GPs with a negative attitude towards screening also exist,
and considering that Amsterdam-based GPs might have specific views, practices, routines, or inter-
ests with regard to screening which might differ from GPs in rural areas or other cities, these results
might not be applicable beyond the described setting.
Since a semi-structured interview guide was used, it is possible that some topics surrounding
CRC screening which are important to GPs were not discussed. However, with regards to the topics
that were discussed, GPs were invited to talk openly and freely. In addition, GPs were given the
opportunity to expand on topics they addressed themselves and were asked if they had anything to
add at the end of the interview.
Finally, as this study was performed at the time when GPs still received standard notifications
about their patients’ positive FIT results, it is not completely representative of the current situation,
where this is no longer the case. However, the authors think that patients will still ask their GPs for
advice on CRC screening and colonoscopy. This is supported by the finding that GPs described
receiving questions from patients who had not yet participated in the screening. Furthermore,
patients are still expected to collect their patient history from their GP, which might create an
opportunity for contact and advice.
Comparison with existing literature
As mentioned in the introduction, previous research has suggested that GPs can have a negative
influence on patients’ decisions to participate in CRC screening and follow-up after a positive screen-
ing result.9,11,16,18 Underlying GP-related factors mentioned are a heavy workload, insufficiency of
training, and a lack of trust in screening.9,11 The authors suspect that another factor might also play
a role: whereas GPs may use reassurance strategies in potentially distressed patients, as was found
in this study, patients might misinterpret this as downgrading the importance of screening. This pos-
sible incongruence between GPs’ and patients’ interpretations would be in line with a recent study
on empathy, suggesting that GPs’ impressions differ from patients’ perceptions.33
Furthermore, these results imply that another possible aspect is GPs’ low risk perception after a
positive FIT result. This is apparent from the emphasis on the high probability of false-positives and
by the comparisons made with the initial result of breast cancer screening, the outcome of which is
seen by some GPs as much more indicative of cancer. The comparison with the breast cancer screen-
ing is especially striking since this is a population screening with a relatively high rate of false-posi-
tives. RIVM reports a false-positive rate of 70.7%.34 This rate concerns referrals after a BI-RADS
finding of 0 (‘not enough information on photo’ = 88% false-positive), 4 (‘suspicious abnormality’ =
58% false-positive), or 5 (‘highly suspicious abnormality’ = 4% false-positive). Relevant findings are
defined by RIVM as ductal carcinomas in situ (a non-invasive condition that may or may not develop
into invasive cancer)35 and invasive carcinomas combined.34 In comparison, if both CRC and AA are
considered relevant findings during colonoscopy, the rate of false-positives of the CRC screening
programme was 49.2% in 2016.4 Arguments to consider AA a relevant finding can be found in the
fact that they represent a small subpopulation of adenomas most likely to develop into
CRC36,37 and that 70–90% of CRC develops from AA.38
Implications for research and practice
This study’s findings suggest that the interviewed GPs’ knowledge of CRC screening may not always
be up-to-date. This may influence their recommendations to patients who ask for advice about the
screening. These results also suggest that simply informing these GPs about the actual rates of CRC
and AA found through the screening programme might change the way they advise their patients
and lead to better-informed decision-making.
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As this was a small scale exploratory study, an investigation on a larger scale might be helpful to
determine if these findings hold true for a larger and more diverse proportion of the GP population.
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21. Rat C, Pogu C, Le Donné D, et al. Effect of physician notification regarding nonadherence to colorectal
cancer screening on patient participation in fecal immunochemical test cancer screening: A randomized
clinical trial. JAMA 2017; 318(9): 816–824. doi: 10.1001/jama.2017.11387
22. Ho MY, Lai JY, Cheung WY. The influence of physicians on colorectal cancer screening behavior. Cancer
Causes Control 2011; 22(12): 1659–1668. doi: 10.1007/s10552-011-9842-4
23. Cole SR, Young GP, Byrne D, et al. Participation in screening for colorectal cancer based on a faecal occult
blood test is improved by endorsement by the primary care practitioner. J Med Screen 2002; 9(4): 147–152.
doi: 10.1136/jms.9.4.147
24. Zajac IT, Whibley AH, Cole SR, et al. Endorsement by the primary care practitioner consistently improves
participation in screening for colorectal cancer: a longitudinal analysis. J Med Screen 2010; 17(1): 19–24.
doi: 10.1258/jms.2010.009101
25. Rex DK, Boland CR, Dominitz JA, et al. Colorectal cancer screening: recommendations for physicians and
patients from the US multi-society task force on colorectal cancer. Am J Gastroenterol 2017; 112(7): 1016–
1030. doi: 10.1038/ajg.2017.174
26. Benton SC, Butler P, Allen K, et al. GP participation in increasing uptake in a national bowel cancer
screening programme: the PEARL project. Br J Cancer 2017; 116(12): 1551–1557. doi: 10.1038/bjc.2017.
129
27. Gemeente Amsterdam. [Key figures, Amsterdam 2017] Kerncijfers gebieden Amsterdam 2017 (in Dutch).
2017; https://www.ois.amsterdam.nl/downloads/pdf/2017_kerncijfers.pdf (accessed 12 Mar 2019).
28. Federici A, Giorgi Rossi P, Bartolozzi F, et al. Survey on colorectal cancer screening knowledge, attitudes,
and practices of general practice physicians in Lazio, Italy. Prev Med 2005; 41(1): 30–35. doi: 10.1016/j.
ypmed.2004.11.010
29. Gemeente Amsterdam. [Neighbourhoods] Buurten (in Dutch). https://www.amsterdam.nl/buurten (accessed
12 Mar 2019).
30. Boeije H. [Analysing in qualitative research] Analyseren in kwalitatief onderzoek (in Dutch). Amsterdam:
Boom, 2016.
31. Bryman A. Social Research Methods. 3rd edn. Oxford: Oxford University Press, 2008.
32. Erasmus Medisch Centrum — Nederlands Kanker Instituut, Antoni van Leeuwenhoek. [Population screening
bowel cancer, Monitor] Bevolkingsonderzoek darmkanker, Monitor (in Dutch). 2015; https://www.rivm.nl/
sites/default/files/2018-11/Monitor%20bvo%20dk%202015%20%28def%29.pdf & (accessed 12 Mar 2019).
33. Hermans L, Olde Hartman TC, Dielissen PW. Differences between GP perception of delivered empathy and
patient-perceived empathy: a cross-sectional study in primary care. Br J Gen Pract 2018; 68(674): e621–
e626. doi: 10.3399/bjgp18X698381
34. Integraal Kankercentrum Nederland (IKNL). [Monitor population screening breast cancer] Monitor
bevolkingsonderzoek borstkanker (in Dutch). 2017; https://www.rivm.nl/sites/default/files/2018-11/Monitor%
20bevolkingsonderzoek%20borstkanker%202015.pdf (accessed 12 Mar 2019).
35. Thomas ET, Del Mar C, Glasziou P, et al. Prevalence of incidental breast cancer and precursor lesions in
autopsy studies: a systematic review and meta-analysis. BMC Cancer 2017; 17(1): 808. doi: 10.1186/s12885-
017-3808-1
36. Vleugels JLA, Hazewinkel Y, Fockens P, et al. Natural history of diminutive and small colorectal polyps:
a systematic literature review. Gastrointest Endosc 2017; 85(6): 1169–1176. doi: 10.1016/j.gie.2016.12.014
37. Kim DH, Pickhardt PJ, Taylor AJ. Characteristics of advanced adenomas detected at CT colonographic
screening: implications for appropriate polyp size thresholds for polypectomy versus surveillance. AJR Am J
Roentgenol 2007; 188(4): 940–944. doi: 10.2214/AJR.06.0764
38. Short MW, Layton MC, Teer BN, et al. Colorectal cancer screening and surveillance. Am Fam Physician 2015;
91(2): 93–100.
Bertels L et al. BJGP Open 2019; DOI: 10.3399/bjgpopen18X101631 10 of 10
Research
